LifeStance Health Group (NASDAQ:LFST – Get Free Report) is anticipated to announce its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $313.96 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.
LifeStance Health Group Trading Down 1.0 %
LFST stock opened at $7.52 on Wednesday. LifeStance Health Group has a 1-year low of $4.64 and a 1-year high of $9.20. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $2.88 billion, a price-to-earnings ratio of -28.90 and a beta of 1.28. The business has a 50 day simple moving average of $7.77 and a two-hundred day simple moving average of $7.20.
Analyst Ratings Changes
Several research analysts have weighed in on LFST shares. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Monday, December 16th. Barclays upped their price target on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $8.70.
About LifeStance Health Group
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
- Five stocks we like better than LifeStance Health Group
- How to Invest in Biotech Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- How to trade using analyst ratings
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- 3 Warren Buffett Stocks to Buy Now
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
